SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019231-24-000024
Filing Date
2024-06-07
Accepted
2024-06-07 18:59:09
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9625
  Complete submission text file 0001019231-24-000024.txt   11625
Mailing Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701
Business Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701 5122251630
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting) CIK: 0001019231 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 0831
Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 241031120

Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)